Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility.
about
Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersmicroRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.Identification of a microRNA signature for the diagnosis of fibromyalgia.Elevated Glucose Levels Promote Contractile and Cytoskeletal Gene Expression in Vascular Smooth Muscle via Rho/Protein Kinase C and Actin PolymerizationMicroRNA Mechanisms of Action: What have We Learned from Mice?Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhagemicroRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.MicroRNAs in Bladder Outlet Obstruction: Relationship to Growth and Matrix Remodelling.Interplay between miRNAs and human diseases.MicroRNA-203 mimics age-related aortic smooth muscle dysfunction of cytoskeletal pathways.Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.MicroRNA-Dependent Control of Serotonin-Induced Pulmonary Arterial Contraction.Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.
P2860
Q26753129-76B9E9BA-F4E5-4D4C-886E-0B93308A26FBQ34504964-20F84B8B-6A10-4E5C-99B2-D7E64B2B04B7Q35214433-1594729F-9294-414D-8CBB-F3D1CBA33FE8Q35873096-EAC916C7-5766-499E-BCA5-401D590F5EAFQ36279977-69D67210-1B68-4241-8710-0A5BA16DCC85Q36775830-BDB14251-748F-4369-B807-7DBBA1955EA4Q37661709-B628A144-A8D8-436E-9EE2-26B77B14C99DQ38379481-E5C5C69D-3B5D-4BD5-AF46-9640698F0766Q38650105-608D3CDE-945F-48CB-9FC2-79D280EB123AQ39127898-36E9ABC3-258E-4934-81A4-E83BEB06CAE7Q40062846-76BB1F28-BF83-4C76-B4AB-28B01DD6ACB7Q40998786-FECF76C3-31F4-473E-B0C0-7A1E4D0A5577Q47968330-ADCCA054-3613-445E-909B-B6012A47DAD1Q54976146-0D374B5F-8884-4B6D-BFD8-1281A55E9A45
P2860
Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Induction of angiotensin-conve ...... d smooth muscle contractility.
@en
type
label
Induction of angiotensin-conve ...... d smooth muscle contractility.
@en
prefLabel
Induction of angiotensin-conve ...... d smooth muscle contractility.
@en
P2093
P2860
P50
P1476
Induction of angiotensin-conve ...... ed smooth muscle contractility
@en
P2093
Anna-Karin Larsson-Callerfelt
Diana Dahan
Karolina Turczyńska
Mari Ekman
Thomas Boettger
P2860
P304
P356
10.1152/AJPCELL.00250.2014
P577
2014-10-01T00:00:00Z